Article Details
Retrieved on: 2018-01-03 09:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. boosted its stake in Synergy Pharmaceuticals by 10.4% in the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 17,422,326 shares of the biopharmaceutical company's stock worth $77,530,000 after purchasing an additional 1,636,563 shares during the period. State Street Corp raised ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here